InMed Pharmaceuticals (INM) Free Cash Flow Growth (1y) (2020 - 2026)
InMed Pharmaceuticals (INM) Free Cash Flow Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | 10.34% |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | -43.16% |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | -12.44% |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 152.68% |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | 44.93% |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | -291.47% |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 24.53% |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | 49.78% |
| 10 | InMed Pharmaceuticals | 5.94 Mn | 696,491.41 | - | -2.15% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.15% |
| Dec 31, 2025 | 5.03% |
| Sep 30, 2025 | 12.00% |
| Jun 30, 2025 | -72.81% |
| Mar 31, 2025 | 14.21% |
| Dec 31, 2024 | -35.39% |
| Sep 30, 2024 | 15.98% |
| Jun 30, 2024 | -49.21% |
| Mar 31, 2024 | -16.76% |
| Dec 31, 2023 | 31.88% |
| Sep 30, 2023 | 3.61% |
| Jun 30, 2023 | 82.96% |
| Mar 31, 2023 | 69.05% |
| Dec 31, 2022 | 18.26% |
| Sep 30, 2022 | 22.33% |
| Jun 30, 2022 | -101.75% |
| Mar 31, 2022 | -16.06% |
| Dec 31, 2021 | -84.27% |
| Sep 30, 2021 | -111.72% |
| Jun 30, 2021 | -43.53% |